A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease

Απλή σελίδα τεκμηρίου
dc.contributor.authorKruger, R.en
dc.contributor.authorSharma, M.en
dc.contributor.authorRiess, O.en
dc.contributor.authorGasser, T.en
dc.contributor.authorVan Broeckhoven, C.en
dc.contributor.authorTheuns, J.en
dc.contributor.authorAasly, J. O.en
dc.contributor.authorAnnesi, G.en
dc.contributor.authorBentivoglio, A. R.en
dc.contributor.authorBrice, A.en
dc.contributor.authorDjarmati, A.en
dc.contributor.authorElbaz, A.en
dc.contributor.authorFarrer, M.en
dc.contributor.authorFerrarese, C.en
dc.contributor.authorGibson, J. M.en
dc.contributor.authorHadjigeorgiou, G. M.en
dc.contributor.authorHattori, N.en
dc.contributor.authorIoannidis, J. P.en
dc.contributor.authorJasinska-Myga, B.en
dc.contributor.authorKlein, C.en
dc.contributor.authorLambert, J. C.en
dc.contributor.authorLesage, S.en
dc.contributor.authorLin, J. J.en
dc.contributor.authorLynch, T.en
dc.contributor.authorMellick, G. D.en
dc.contributor.authorde Nigris, F.en
dc.contributor.authorOpala, G.en
dc.contributor.authorPrigione, A.en
dc.contributor.authorQuattrone, A.en
dc.contributor.authorRoss, O. A.en
dc.contributor.authorSatake, W.en
dc.contributor.authorSilburn, P. A.en
dc.contributor.authorTan, E. K.en
dc.contributor.authorToda, T.en
dc.contributor.authorTomiyama, H.en
dc.contributor.authorWirdefeldt, K.en
dc.contributor.authorWszolek, Z.en
dc.contributor.authorXiromerisiou, G.en
dc.contributor.authorMaraganore, D. M.en
dc.date.accessioned2015-11-24T19:40:18Z
dc.date.available2015-11-24T19:40:18Z
dc.identifier.issn1558-1497-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24333
dc.rightsDefault Licence-
dc.subjectAgeden
dc.subjectChi-Square Distributionen
dc.subjectCohort Studiesen
dc.subjectEuropean Continental Ancestry Group/ethnologyen
dc.subjectFemaleen
dc.subjectGene Frequencyen
dc.subject*Genetic Predisposition to Diseaseen
dc.subjectGenome-Wide Association Studyen
dc.subjectGenotypeen
dc.subjectHumansen
dc.subjectInternational Cooperationen
dc.subjectMaleen
dc.subjectMeta-Analysis as Topicen
dc.subjectMiddle Ageden
dc.subjectMitochondrial Proteins/*geneticsen
dc.subjectParkinson Disease/epidemiology/*ethnology/*geneticsen
dc.subjectPolymorphism, Single Nucleotide/*geneticsen
dc.subjectSerine Endopeptidases/*geneticsen
dc.titleA large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's diseaseen
heal.abstractHigh-profile studies have provided conflicting results regarding the involvement of the Omi/HtrA2 gene in Parkinson's disease (PD) susceptibility. Therefore, we performed a large-scale analysis of the association of common Omi/HtrA2 variants in the Genetic Epidemiology of Parkinson's disease (GEO-PD) consortium. GEO-PD sites provided clinical and genetic data including affection status, gender, ethnicity, age at study, age at examination (all subjects); age at onset and family history of PD (patients). Genotyping was performed for the five most informative SNPs spanning the Omi/HtrA2 gene in approximately 2-3 kb intervals (rs10779958, rs2231250, rs72470544, rs1183739, rs2241028). Fixed as well as random effect models were used to provide summary risk estimates of Omi/HtrA2 variants. The 20 GEO-PD sites provided data for 6378 cases and 8880 controls. No overall significant associations for the five Omi/HtrA2 SNPs and PD were observed using either fixed effect or random effect models. The summary odds ratios ranged between 0.98 and 1.08 and the estimates of between-study heterogeneity were not large (non-significant Q statistics for all 5 SNPs; I(2) estimates 0-28%). Trends for association were seen for participants of Scandinavian descent for rs2241028 (OR 1.41, p=0.04) and for rs1183739 for age at examination (cut-off 65 years; OR 1.17, p=0.02), but these would not be significant after adjusting for multiple comparisons and their Bayes factors were only modest. This largest association study performed to define the role of any gene in the pathogenesis of Parkinson's disease revealed no overall strong association of Omi/HtrA2 variants with PD in populations worldwide.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1016/j.neurobiolaging.2009.11.021-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20036034-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0197458009003911/1-s2.0-S0197458009003911-main.pdf?_tid=6f5de4ef9470af781943452355915e0c&acdnat=1333363579_1334f94a17a7af976eabf0bf6e561944-
heal.journalNameNeurobiol Agingen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2011-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ